Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

钇[90Y]微球注射液 - NMPA Drug Approval Details

Approvals/NMPA/Yttrium-90 Microsphere Injection

Approved

化学药品

Yttrium-90 Microsphere Injection

SIRTEX MEDICAL PTY LTD🇨🇳 National Medical Products Administration

Approval Date: Jan 30, 2022
Approval ID: 8DqcFQKdEI7
Company: SIRTEX MEDICAL PTY LTD
Type: 化学药品

Approval Details

Approval Id: 8DqcFQKdEI7
Approval Number: 国药准字HJ20220004
Generic Name: 钇[90Y]微球注射液
Generic Name En: Yttrium-90 Microsphere Injection
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 3 GBq±10%（在校准时间）
Reg Date: 2022-01-30
Expired Date: 2027-01-29
Company Name: SIRTEX MEDICAL PTY LTD
Company Detail Path: /organization/sirtex-medical-pty-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 30, 2022

Approval ID

8DqcFQKdEI7

Type

化学药品

Back to NMPA Approvals